L&C Bio Financial Health

Short Term Liabilities: A290650's short term assets (₩54.9B) exceed its short term liabilities (₩15.6B).

Long Term Liabilities: A290650's short term assets (₩54.9B) do not cover its long term liabilities (₩75.5B).

Debt Level: A290650's net debt to equity ratio (57.9%) is considered high.

Reducing Debt: Insufficient data to determine if A290650's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A290650's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: A290650's interest payments on its debt are well covered by EBIT (9.6x coverage).

• Healthy companies in the Pharmaceuticals & Biotech industry.